Literature DB >> 30457023

Psoriasis and cardiovascular disease: the elusive link.

Antonis A Manolis1, Theodora A Manolis2, Helen Melita3, Antonis S Manolis4.   

Abstract

Psoriasis, an autoimmune inflammatory disease, with its most common coexisting condition, psoriatic arthritis, seem to be more than just a local skin or joint disease, as evidence has accumulated over the years that it is associated with cardiovascular disease (CVD), which may confer an increased cardiovascular event and death rate. The data come mostly from observational studies and meta-analyses and indicate a potential pathogenetic link between these two systemic diseases, however definite proof of this detrimental relationship awaits further prospective studies. Newer anti-psoriatic biologic therapies seem to confer a cardiovascular benefit, but this needs future randomized controlled studies to confirm. All these intricate issues of a potential link between psoriasis and CVD are discussed and elaborated in this overview, in an attempt to shed further light on pivotal aspects of the association between psoriasis and CVD.

Entities:  

Keywords:  Psoriasis; cardiovascular disease; coronary artery disease; dyslipidemia; hypertension; metabolic syndrome; myocardial infarction; psoriatic arthritis

Mesh:

Substances:

Year:  2018        PMID: 30457023     DOI: 10.1080/08830185.2018.1539084

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  12 in total

Review 1.  Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis.

Authors:  Yan Wang; Jinxin Zang; Chen Liu; Zhongrui Yan; Dongmei Shi
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

2.  Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis.

Authors:  Rachael M Hewitt; Rachael Pattinson; Lis Cordingley; Christopher E M Griffiths; C. Elise Kleyn; Helen McAteer; Julia Schofield; Chris Bundy
Journal:  Acta Derm Venereol       Date:  2021-04-29       Impact factor: 3.875

3.  Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice.

Authors:  Yan Hao; Pei Zhou; Ya-Juan Zhu; Song Zou; Qixiang Zhao; Jiadong Yu; Yawen Hu; Jiong Li
Journal:  Front Microbiol       Date:  2022-04-14       Impact factor: 5.640

4.  Causal Biological Network Model for Inflammasome Signaling Applied for Interpreting Transcriptomic Changes in Various Inflammatory States.

Authors:  Hasmik Yepiskoposyan; Manuel C Peitsch; Marja Talikka
Journal:  Int J Inflam       Date:  2022-01-27

5.  An Emerging Role of Proanthocyanidins on Psoriasis: Evidence from a Psoriasis-Like Mouse Model.

Authors:  Yang Yang; Yangmeng Zhao; Rui Lai; Li Xian; Qirong Lei; Jixiang Xu; Menglu Guo; Dehai Xian; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

Review 6.  Cardiovascular Involvement in Psoriasis, Diagnosing Subclinical Atherosclerosis, Effects of Biological and Non-Biological Therapy: A Literature Review.

Authors:  Sharathshiva Valaiyaduppu Subas; Vinayak Mishra; Vishal Busa; Ishan Antony; Suganya Marudhai; Mauli Patel; Ivan Cancarevic
Journal:  Cureus       Date:  2020-10-26

Review 7.  Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk.

Authors:  Maria J E Visser; Gareth Tarr; Etheresia Pretorius
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

8.  The Impact of Hypertension, Diabetes, Lipid Disorders, Overweight/Obesity and Nicotine Dependence on Health-Related Quality of Life and Psoriasis Severity in Psoriatic Patients Receiving Systemic Conventional and Biological Treatment.

Authors:  Anna Karpińska-Mirecka; Joanna Bartosińska; Dorota Krasowska
Journal:  Int J Environ Res Public Health       Date:  2021-12-14       Impact factor: 3.390

9.  The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis.

Authors:  Suiyuan Hu; Chu Lin; Xiaoling Cai; Xingyun Zhu; Fang Lv; Lin Nie; Linong Ji
Journal:  Mediators Inflamm       Date:  2021-08-31       Impact factor: 4.711

Review 10.  Adiponectin in psoriasis and its comorbidities: a review.

Authors:  Bai Ruiyang; Fu Siqi; Adriana Panayi; Wu Ruifang; Zhang Peng
Journal:  Lipids Health Dis       Date:  2021-08-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.